Stock Price Quote

ALPA LABORATORIES LTD.

NSE : ALPABSE : 532878ISIN CODE : INE385I01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE96.930.6 (+0.62 %)
PREV CLOSE ( ) 96.33
OPEN PRICE ( ) 100.99
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 33650
TODAY'S LOW / HIGH ( )96.35 100.99
52 WK LOW / HIGH ( )50.06 106.5
NSE97.000.7 (+0.73 %)
PREV CLOSE( ) 96.30
OPEN PRICE ( ) 97.25
BID PRICE (QTY) 97.00 (292)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 95525
TODAY'S LOW / HIGH( ) 96.40 98.50
52 WK LOW / HIGH ( )50.3 106.6
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1988
Management Info
Mahendra Singh Chawla - Chairman Paresh Chawla - Managing Director
Registered Office

Address 33/2 Pigdamber,A B Road ,Rau,
Indore Dist,
Madhya Pradesh-453446

Phone 0731-4294567

Email mail@alpalabs.in

Website www.alpalabs.in

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
 Listing : BSE, NSE

NEWS

24Nov Alpa Laboratories informs about RPT di
Alpa Laboratories has informed that it has submitted the disclosure of R..
14Jun Alpa Laboratories informs about disclo
Alpa Laboratories has submitted the disclosure under Regulations 10(6) o..
01Jan Alpa Laboratories informs about closur
Pursuant of Securities and Exchange Board of India (Prohibition of Insid..
03Oct Alpa Laboratories informs about closur
Pursuant of Securities and Exchange Board of India (Prohibition of Insid..
22Jan Alpa Laboratories submits clarification
With reference to significant movement in price, in order to ensure that..
MORE

Financials

in Millions
QTR Sep 23 ANNUAL 23
Net Profit57.39126.26
Gross Profit 57.39 159.34
Operating Profit 62.68174.85
Net Sales 323.94924.36
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  8215.50 (2.40%)
M.Cap ( in Cr)18920.81
Coral Laboratories (BSE)
peergroup  483.40 (16.45%)
M.Cap ( in Cr)172.70
Caplin Point Lab (BSE)
peergroup  1293.05 (3.16%)
M.Cap ( in Cr)9819.52
Gland Pharma (BSE)
peergroup  1807.45 (1.89%)
M.Cap ( in Cr)29769.05
Mankind Pharma (BSE)
peergroup  1917.20 (1.73%)
M.Cap ( in Cr)76800.82
MORE

Shareholding Pattern

PROMOTERS 57.29%
NON-INSTITUTION 42.6%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
MORE

About Alpa Laboratories Ltd.

Alpa Laboratories Ltd. was incorporated in the year 1988. Its today's share price is 96.93. Its current market capitalisation stands at Rs 203.95 Cr. In the latest quarter, company has reported Gross Sales of Rs. 929.55 Cr and Total Income of Rs.1023.64 Cr. The company's management includes Pratibha Lunawat, Saket Baheti, Sunil Valecha, Swati Bagh, Vitthal Kothana, Jyoti Jain, Krishna Das Malani, Sharad Chand Lunawat, Devendra Baheti, Pravin Shah, Paresh Chawla, Mahendra Singh Chawla.

It is listed on the BSE with a BSE Code of 532878 , NSE with an NSE Symbol of ALPA and ISIN of INE385I01010. It's Registered office is at 33/2 Pigdamber,A B Road ,RauIndore Dist-453446, Madhya Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Anuradha Ratnaparkhi & Associates, CH Padliya & Co

download beyond app
download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal BangContact Dp Support Contact Trading Support
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays T+1 Settlement securities
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX HolidaysMCX Data feed product and Charges
Portfolio Management Service (PMS) NBSPL - PMS Disclosure Nirmal Bang PMS - Investor Charter
Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Mutual Fund Terms & Conditions Mutual Privacy Policy
NPS NPS Forms and Guidelines
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap Do's And Dont'sInvestor Complaint Data
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Risk Disclosure Grievances NPS Grievance Policy SEBI ScoresRMS Policy Inspection CSR Committee CSR Policy
CSR Activities
FY-2020-2021 FY-2021-2022 FY-2022-2023
Investor Charter
Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs Investor Charter for Stock Broker Investor Charter for Research Investor Complaints -RA Investor Complaints-NBEPL
Evoting
NSDL Evoting CDSL Evoting
Client Bank Account list Smartodr Login Investor Grievance Flow Registered AP’sSurrendered List of AP’sKYC Activation Process
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL PMS Disclosure Document
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment INZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.